Highlights: 401 fresh cases push Nagpur's Covid-19 tally to 111,190
AstraZeneca could run an additional global trial to assess the efficiency of its Covid-19 vaccine. Experts have proposed the first supply of Covid-19 vaccines to frontline workers.
- 08:33 AM IST
- 08:18 AM IST
- 07:49 AM IST
- 07:30 AM IST
- 07:30 AM IST
The overall tally of Coronavirus cases in India currently stands at 9,309,787. The country had recorded 43,082 fresh Covid-19 cases and 492 deaths in the last 24 hours, as per the official data of Union Health Ministry. The preparation for Covid-19 vaccine is in full swing. Russia has agreed to make 100 million doses of its Covid-19 vaccine Sputnik V in collaboration with the Indian pharmaceutical company Hetero in India. Phase-3 trial of Covaxin — the indigenous vaccine being developed by Bharat Biotech — began in Ahmedabad on Thursday.
Prime Minister Narendra Modi is on a three-city tour to review the status of vaccine development in India. After Zydus Biotech Park in Ahmedabad, he is slated to visit Bharat Biotech in Hyderabad and Serum Institute of India facilities in Pune.
The Philippines has secured over 2.6 million doses of the Covid-19 vaccine being developed by AstraZeneca. The UK has moved to get approval for the AstraZeneca vaccine before the EU to boost up the vaccine supply. Ireland is planning to ease the restrictions imposed to control Covid-19 ahead of Christmas.
Italy to ease Covid-19 restrictions
The Italian government will ease anti-Covid restrictions in five regions from Sunday, including in the country's richest and most populous region Lombardy, the Health Ministry said., reports Reuters.
Covid-19 rate slows in France ahead of shops reopening
The rate of new coronavirus infections slowed again in France on Friday, the day before shops can resume selling non-essential goods, health ministry data showed, reports Reuters.
PM Modi to vist three cities to review Covid-19 vaccine development
Gujarat: PM Narendra Modi to visit Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad & Serum Institute of India in Pune today to personally review the #COVID19 vaccine development and manufacturing process.— ANI (@ANI) November 28, 2020
Visuals from Zydus Biotech Park in Ahmedabad. pic.twitter.com/sAE3b2cWgO
Ten Covid-19 vaccines expected by mid next year: global pharma industry head
Ten Covid-19 vaccines could be available by the middle of next year if they win regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday, reports Reuters.
Mexico records 12,081 new Covid-19 cases and 631 deaths
Mexico's Health Ministry on Friday reported 12,081 additional cases of the novel coronavirus and 631 more deaths in the country, bringing the official number of infections to 1,090,675 and the death toll to 104,873, reports Reuters.
First published: Nov 28, 2020 07:10 IST